Get ready for an extraordinary convergence of brilliance at the CPHI South East Asia 2024, the esteemed trade exhibition, and conference platform tailored for the pharmaceutical industry in Southeast Asia. Organized with precision by Informa Markets, this landmark event is set to make waves from 10-12 July 2024 at the iconic Queen Sirikit National Convention Center, Bangkok, Thailand. Picture an assembly that’s not only about pharmaceuticals but also intertwines seamlessly with the Medlab Asia & Asia Health 2024, all under the grand umbrella of “International Healthcare Week.” This synergistic event supports Thailand’s visionary goal to be the medical nucleus of ASEAN, bolstering its economic dynamism and competitive prowess.
Anticipate an impressive showcase of cutting-edge products, breakthrough technologies, and awe-inspiring innovations sweeping across Thailand’s burgeoning medical, medical labs, and pharmaceutical sectors. With a magnetic pull, the event is primed to draw over 400 global brands spanning 10 distinct business sectors. The knowledge repository promises to brim with over 60 meticulously curated conference topics, each sculpting new business avenues and fostering unparalleled networking opportunities.
In the words of Mr. Manu Leopairote, the illustrious Chairman of Informa Markets Thailand, this colossal gathering embraces the ethos of “International Healthcare Week.” By intertwining three pivotal events—CPHI South East Asia 2024, Medlab Asia 2024, and Asia Health 2024—the focus extends to professionals immersed in pharmaceutical products and services, medical labs, medical equipment, and pioneering healthcare solutions, covering the entire pharmaceutical value chain.
Ms. Rungphech Chitanuwat, the dynamic Regional Portfolio Director – ASEAN, and Country General Manager – Philippines, unveils the readiness for CPHI South East Asia 2024, a beacon of pharmaceutical technology and innovation in Asia. The mission? To carve new vistas and uplift the Thai pharmaceutical industry, fortifying pharmaceutical security and propelling Thailand to the zenith as ASEAN’s premier and rapidly evolving medical hub.
Amidst a landscape where the Thai pharmaceutical industry relies heavily on imports, a golden horizon of export opportunities unfurls for diligent Thai producers. This year’s exhibition, Ms. Rungphech articulates, pivots towards amplifying producers’ latent potential and sculpting fresh business possibilities. CPHI South East Asia 2024 emerges as the solitary event uniting trustworthy producers, stellar products, avant-garde solutions, and trailblazing production innovations.
Delight in the vibrant tapestry where over 400 brands from 50 diverse nations, including the Philippines, Myanmar, Indonesia, Singapore, Vietnam, and Cambodia, converge. Witness a spectacle featuring healthcare and medical marvels from 10 related industry profiles, encompassing reactants, medicine, herbal remedies, precision machinery, packaging wonders, testing equipment, robust OEM solutions, logistics, warehousing, dynamic chemicals, and natural extracts.
The event promises more than just exhibitions. It is an engine for collaborative growth, offering networking opportunities and workshops geared towards sustainable industry practices. Engage in enriching seminars on contemporary industry trends and thought-provoking topics, culminating in the exhilarating Pharma Quest, a competition celebrating pharmaceutical expertise.
One cannot overlook the innovation exhibition, a global gathering of 400 brands that offers a glimpse into the future of healthcare systems and unveils burgeoning business opportunities. This confluence allows participants to stay abreast of industry currents, seek sage advice on pharmaceutical product registration procedures across ASEAN realms like Malaysia, the Philippines, Vietnam, China, Indonesia, and Thailand, and learn the nuances of medical equipment procurement—a treasure trove for aspiring business magnates in ASEAN.
At its core, CPHI South East Asia 2024 aspired to bolster pharmaceutical security, advocate for high-quality pharmaceutical access, and escalate Thailand’s stature as ASEAN’s healthcare and medical epicenter. This is particularly pertinent given the current import-heavy landscape where 70% of medical products come from abroad, presenting a tantalizing growth vista for Thai manufacturers as OEMs and exporters.
In this ever-evolving business realm, challenges abound for medical and pharmaceutical producers. Yet, so do golden opportunities, spurred by a shifting demographic landscape and the burgeoning ageing society. With the ageing population expanding by 7.5% annually, paired with a rising influx of non-communicable diseases (NCD) patients, the demand for superior medicines soars. IQVIA’s insightful market research reveals that the Thai pharmaceutical market holds substantial value at 180 billion baht, with an impressive yearly growth rate of 11%.
Ms. Rungphech expounds that CPHI South East Asia 2024 aligns perfectly with Medlab Asia & Asia Health 2024, presenting a cohesive exhibition of upstream, midstream, and downstream products and technologies. It’s an intellectual hub where seminars and meetings brim with updated trends, advanced technological insights, and fresh business opportunities.
To sum it up, CPHI South East Asia 2024 stands as a beacon for the pharmaceutical industry in Southeast Asia, fostering growth through unerring networking. Happening from 10-12 July 2024 at Hall 1-3, QSNCC, Bangkok, the event anticipates drawing an impressive 8,000 visitors. Eager attendees can secure their visit by registering at www.cphi.com/sea.
This event sounds incredible! Bringing so many global brands into one place can really transform Thailand into a major pharma hub for ASEAN.
I agree, Sarah. It’s a huge step forward for the Thai pharmaceutical industry. But do you think our domestic producers are ready to compete on such a big stage?
It’s definitely a challenge, but with the government and industry backing them, they might just pull it off.
Domestic producers need to step up their game, undeniably. Quality control and innovation will be key.
What concerns me is the heavy reliance on imports. 70% of medical products are from abroad? We’re just asking for trouble if there’s a global supply chain disruption.
That’s exactly why this event is important. It can help reduce dependency by boosting local production.
True, but it’s going to take time to shift from imports to local manufacturing. What happens in the meantime?
Sophia, exactly. We’re still vulnerable in the interim and might face shortages before local production ramps up.
I’m just excited about the new technologies being showcased. Hopefully, this includes advancements in herbal remedies. Thailand has such a rich history in that field.
Absolutely! Herbal remedies combined with modern pharmaceutical practices could be groundbreaking.
I think we should be cautious. Big pharma has not always had the best interests at heart. Will these events genuinely benefit local communities or just enrich the big corporations?
Networking opportunities and workshops on sustainable practices might sound good on paper, but are they actually making a difference? It’s all about practical implementation.
Jenny, you’re right. We need transparency in how these practices are being implemented and measured.
This event could be monumental for the ASEAN region if executed correctly. The trick will be balancing international influence with local growth.
Do we have the infrastructure to support such a massive influx of global brands? Thailand is developing, but are we ready for something on this scale?
Valid point, Ying. The government will need to invest heavily in infrastructure improvements.
CPHI South East Asia 2024 aligning with Medlab Asia seems perfect, but why hasn’t Thailand become a pharma hub sooner? What’s been holding us back?
Good question, Emre. One issue might be the lack of investment in research and development historically. We’re starting to catch up now.
I think it’s also been partly due to political and economic instability. Consistency in policies can make a huge difference.
Ying’s right. Stable policies can attract more investment and foster a conducive environment for growth.
I’m optimistic but wary. While these events are excellent networking opportunities, they also come with the risk of monopolies forming if not regulated properly.
I really hope this event provides genuine learning opportunities for local students and young professionals who want to enter the pharmaceutical field.
Does anyone actually believe this event will solve our healthcare issues? Feels more like a shiny distraction than a real solution.
It’s not a cure-all, but it’s a step in the right direction. Real change takes time and multiple initiatives.
thaitiger, you’re not wrong. It’s important to keep realistic expectations but also support steps toward progress.
The inclusion of seminars and competitions like Pharma Quest sounds excellent. It could really drive innovation and push young talents to the forefront.
I’m more interested in the impact on local farmers. If pharmaceutical companies start focusing more on herbal remedies, it could really benefit our agriculture.
Pharmaceutical security is crucial, but what about accessibility? How will these events ensure that advancements reach the lower-income segments of society?
Great point, Max. Ensuring accessibility should be a priority. Development means nothing if it doesn’t benefit everyone.
I’m curious about the logistics of exporting these pharmaceutical products. Are Thai producers well-versed in international regulations and standards?
Ravi, they’ll need to be if they want to compete on the global stage. It’s a huge learning curve but necessary.
While aiming to become a medical hub is great, it shouldn’t come at the expense of local health needs. Balance is key.
As someone who’s attended similar events, I can say the insights gained from networking can be invaluable. I hope local businesses really capitalize on this.